» Authors » Caitlin OCallaghan

Caitlin OCallaghan

Explore the profile of Caitlin OCallaghan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 245
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
OCallaghan C, Rogan P, Brigo F, Rahilly J, Kinney M
Epilepsy Behav . 2021 May; 121(Pt A):108033. PMID: 34023811
Introduction: People with epilepsy can have cognitive deficits, including difficulty with reading tasks. This can potentially impact on how written information is understood. Websites increasingly provide information about different medical...
2.
Yamakawa S, Wu D, Dasgupta M, Pedamallu H, Gupta B, Modi R, et al.
Am J Physiol Heart Circ Physiol . 2021 Feb; 320(4):H1658-H1669. PMID: 33635163
The goal of this work was to investigate the role of t-tubule (TT) remodeling in abnormal Ca cycling in ventricular myocytes of failing dog hearts. Heart failure (HF) was induced...
3.
Lee S, OCallaghan C, Aw K, Rogan P, Kinney M, Hawkins S
Ulster Med J . 2020 Oct; 89(2):95-100. PMID: 33093694
The Queen's University Belfast Brain Society was set up in September 2018 to promote interest in the human brain. There were three main goals: firstly to provide opportunities for medical...
4.
Gussak G, Marszalec W, Yoo S, Modi R, OCallaghan C, Aistrup G, et al.
Circ Arrhythm Electrophysiol . 2020 May; 13(6):e008179. PMID: 32433891
Background: We have identified a novel form of abnormal Ca wave activity in normal and failing dog atrial myocytes which occurs during the action potential (AP) and is absent during...
5.
Rodchenkov I, Babur O, Luna A, Aksoy B, Wong J, Fong D, et al.
Nucleic Acids Res . 2019 Oct; 48(D1):D489-D497. PMID: 31647099
Pathway Commons (https://www.pathwaycommons.org) is an integrated resource of publicly available information about biological pathways including biochemical reactions, assembly of biomolecular complexes, transport and catalysis events and physical interactions involving proteins,...
6.
Kulkoyluoglu-Cotul E, Smith B, Wrobel K, Zhao Y, Chen K, Hieronymi K, et al.
Cancers (Basel) . 2019 Apr; 11(4). PMID: 30987380
A majority of breast cancer specific deaths in women with ERα (+) tumors occur due to metastases that are resistant to endocrine therapy. There is a critical need for novel...
7.
Rothman R, Safiia M, Lowry P, Mela T, Abbara S, OCallaghan C, et al.
J Cardiol Cases . 2018 Dec; 3(2):e65-e67. PMID: 30532839
Background: The importance of risk stratification for sudden cardiac death (SCD) after septal myectomy for hypertrophic obstructive cardiomyopathy (HOCM) has not been emphasized previously. Methods And Results: We report 2...
8.
Shimada Y, Passeri J, Baggish A, OCallaghan C, Lowry P, Yannekis G, et al.
JACC Heart Fail . 2014 Mar; 1(6):480-7. PMID: 24621999
Objectives: The aim of this study was to evaluate the effects of losartan on left ventricular (LV) hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy (HCM). Background: Despite evidence...
9.
Inglessis I, Elmariah S, Rengifo-Moreno P, Margey R, OCallaghan C, Cruz-Gonzalez I, et al.
JACC Cardiovasc Interv . 2013 Nov; 6(11):1176-83. PMID: 24262618
Objectives: This study sought to examine the frequency of indications for and the immediate and long-term clinical outcomes of transcatheter closure of patent foramen ovale (PFO). Background: Transcatheter PFO closure...
10.
Rothman R, Baggish A, OCallaghan C, Lowry P, Bhatt A, MacRae C, et al.
Am J Cardiol . 2012 Jul; 110(8):1169-74. PMID: 22766229
The likelihood of success of conservative management of obstructive hypertrophic cardiomyopathy (HC) and the predictors of failure of conservative therapy are not known. We therefore evaluated the efficacy of an...